Company / Net Income
Beam Therapeutics Inc. Net Income History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$80.0M
FY2025
5-year range
-$376.7M / -$80.0M
FY2021-FY2025
Trend
+78.8%
vs FY2024
Sector context
#97 of 216
Health Care
What the data says
At -$80M, Beam Therapeutics Inc.'s net income ranks #97 of 216 in the Health Care sector. Net Income has fluctuated over the past 7 years, ranging from -$377M in FY2024 to -$78M in FY2020.
Based on SEC 10-K filings.
-$80M in FY2025.
Improved from -$133M to -$80M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#97 of 216 in Health CareTop 45% of 216This company -$80.0M Sector average $454.3M
▼
-117.6% below sector average
Key checks
Key Insights
- In FY2025, net income increased 78.8% year-over-year.
- Ranks #97 out of 216 companies in the Health Care sector.
- Peak net income was recorded in FY2020.
- Lowest net income in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 1.06 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$80.0M | +78.8% |
| FY2024 | -$376.7M | -184.3% |
| FY2023 | -$132.5M | +54.2% |
| FY2022 | -$289.1M | +22.0% |
| FY2021 | -$370.6M | -373.2% |
| FY2020 | -$78.3M | +0.0% |
| FY2019 | -$78.3M | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026